Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand
Name:
advancesadv2021006133.pdf
Size:
1.040Mb
Format:
PDF
Description:
Final Published Version
Author
Stoller, M.L.Basak, I.
Denorme, F.
Rowley, J.W.
Alsobrooks, J.
Parsawar, K.
Nieman, M.T.
Yost, C.C.
Hamilton, J.R.
Bray, P.F.
Campbell, R.A.
Affiliation
Analytical and Biological Mass Spectrometry Core Facility, University of ArizonaIssue Date
2022
Metadata
Show full item recordPublisher
American Society of HematologyCitation
Stoller, M. L., Basak, I., Denorme, F., Rowley, J. W., Alsobrooks, J., Parsawar, K., Nieman, M. T., Yost, C. C., Hamilton, J. R., Bray, P. F., & Campbell, R. A. (2022). Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand. Blood Advances.Journal
Blood AdvancesRights
Copyright © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC ND 4.0).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Platelet-neutrophil interactions regulate ischemic vascular injury. Platelets are activated by serine proteases that cleave protease-activated receptor (PAR) amino termini, resulting in an activating tethered ligand. Neutrophils release cathepsin G (CatG) at sites of injury and inflammation, which activates PAR4 but not PAR1, although the molecular mechanism of CatG-induced PAR4 activation is unknown. We show that blockade of the canonical PAR4 thrombin cleavage site did not alter CatG-induced platelet aggregation, suggesting CatG cleaves a different site than thrombin. Mass spectrometry analysis using PAR4 N-terminus peptides revealed CatG cleavage at Ser67-Arg68. A synthetic peptide, RALLLGWVPTR, representing the tethered ligand resulting from CatG proteolyzed PAR4, induced PAR4-dependent calcium flux and greater platelet aggregation than the thrombin-generated GYPGQV peptide. Mutating PAR4 Ser67or Arg68 reduced CatG-induced calcium flux without affecting thrombin-induced calcium flux. Dog platelets, which contain a conserved CatG PAR4 Ser-Arg cleavage site, aggregated in response to human CatG and RALLLGWVPTR, while mouse (Ser-Gln) and rat (Ser-Glu) platelets were unresponsive. Thus, CatG amputates the PAR4 thrombin cleavage site by cleavage at Ser67-Arg68 and activates PAR4 by generating a new functional tethered ligand. These findings support PAR4 as an important CatG signaling receptor and suggest a novel therapeutic approach for blocking platelet-neutrophil-mediated pathophysiologies. © 2022 by The American Society of Hematology.Note
Open access articleISSN
2473-9529PubMed ID
34883511Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1182/bloodadvances.2021006133
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC ND 4.0).

